KKR Said to Mull Stake Sale in India’s $3B JB Pharma

KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter. The US private equity firm is looking to hire financial advisers to help evaluate a sale of its 53.8% stake in the Mumbai-based company, the people said, asking not to be identified as the matter is private. Other buyout firms and industry players have shown preliminary interest in buying KKR’s stake, the people said.

Read the full article: KKR Said to Mull Stake Sale in India’s $3B JB Pharma //

Source: https://news.bloomberglaw.com/mergers-and-acquisitions/kkr-said-to-mull-stake-sale-in-indias-3-billion-jb-pharma-1

Scroll to Top